Nymox Pharmaceutical Corporation - NYMX

About Gravity Analytica
Recent News
- 03.11.2025 - Nymox Announces Dismissal of Delaware Action Against Ascella
- 12.17.2024 - NYMOX Announces Trading Resumed and New Listing on OTCQB Market
- 08.30.2024 - Nymox Announces Filing of Annual Report
- 07.18.2024 - Nymox Annual Report
- 07.16.2024 - Nymox Required to Resubmit Application to DKMA
- 07.16.2024 - Nymox Required to Resubmit Application to DKMA
- 03.27.2024 - Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
- 03.27.2024 - Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
- 12.27.2023 - Nymox December 27 Message to Shareholders
- 12.27.2023 - Nymox December 27 Message to Shareholders
Recent Filings
- 01.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 01.02.2025 - EX-99.1 EX-99.1
- 12.17.2024 - EX-99.1 EX-99.1
- 12.17.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 08.29.2024 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 07.18.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 07.16.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.13.2024 - 6-K 6-K
- 03.28.2024 - 6-K 6-K